BioCentury
ARTICLE | Company News

CSL sales and marketing update

January 7, 2013 8:00 AM UTC

CSL's CSL Behring subsidiary launched a financial assistance program in the U.S. to cover patient's out-of-pocket expenses for hereditary angioedema (HAE) drug Berinert. The program will cover up to ...